| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10753804 | Biochemical and Biophysical Research Communications | 2014 | 8 Pages |
Abstract
Protocadherin 9 (PCDH9) was found frequently lost in hepatocellular carcinoma (HCC). Here we investigated the role of PCDH9 in the development of HCC. We confirmed that PCDH9 was down-regulated in HCC tissues and cell lines compared with the adjacent non-tumor tissues. PCDH9 downregulation was significantly associated with malignant portal vein invasion of HCC patients. Gain- and loss-of-function studies revealed that downregulation of PCDH9 facilitated tumor cell migration and epithelial-mesenchymal transition (EMT). We identified PCDH9 as a novel regulator of EMT by increasing the activity of GSK-3β and inhibiting Snail1, indicating its potential therapeutic value for reducing metastasis of HCC.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Pengfei Zhu, Jun Lv, Ziwei Yang, Limei Guo, Ling Zhang, Meng Li, Wenling Han, Xiangmei Chen, Hui Zhuang, Fengmin Lu,